Source – https://alkhaleejtoday.co/
The European Medicines Agency has approved an injection of AIDS treatment, which sets a precedent for changing the lives of millions of people with HIV, or those known as “seropositive”.The treatment mixes two antiretrovirals, and it can be given to the patient once every month or two, instead of taking daily pills to contain the disease, the agency said in a statement.
The Foundation indicated that these two antagonists are the “first” that are found to have a “long-term” effect through injection.She stated that “patients will receive intramuscular injections once every month or two instead of daily medication pills,” according to “France Press”.
The agency’s recommendation to allow this treatment to be marketed must obtain approval from the European Commission, in order for it to be put on the market in the EU’s 27 countries.
The agency indicated that the combination of the two anti-retroviral drugs “Rilpivirin” and “Capotegravir”, which will be sold under the names of “Recampase” and “Vocabria”, helps in “preventing the ability of the virus to reproduce.”
The number of people living with AIDS in the world reached 38 million in 2019, including 2.3 million in Europe, according to the World Health Organization.This disease has no cure yet, but antiretrovirals can control virus progression and contribute to avoiding transmission.
These were the details of the news A new treatment for AIDS by injection for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.